Literature DB >> 12485126

Polaprezinc attenuates Helicobacter pylori-associated gastritis in Mongolian gerbils.

Ryu Ishihara1, Hiroyasu Iishi, Noriko Sakai, Hiroyuki Yano, Noriya Uedo, Hiroyuki Narahara, Kazushige Iseki, Tomiko Mikuni, Shingo Ishiguro, Masaharu Tatsuta.   

Abstract

BACKGROUND: The ammonia-monochloramine system plays an important role in Helicobacter pylori-associated gastric mucosal injury. Polaprezinc, a new antiulcer agent, has a scavenging action against monochloramine. The aim of the experiment was to investigate the inhibitory effects of polaprezinc on the H. pylori-induced gastritis in Mongolian gerbils.
MATERIALS AND METHODS: Mongolian gerbils fasting for 24 hours were orally given culture broth containing 2-4 x 10(8) colony-forming units of H. pylori ATCC 43054 per milliliter. From 4 hours after inoculation until the end of the experiment, gerbils were given chow pellets with or without 0.02% polaprezinc. All gerbils were killed 12 weeks later. The grades of H. pylori density and histologic features of gastritis were evaluated in accordance with the Updated Sydney System. The scavenging effect of polaprezinc on monochloramine was investigated spectrophotometrically.
RESULTS: Polaprezinc had little or no influence on the H. pylori density in both pyloric and fundic mucosae. However, it significantly attenuated the development of polymorphonuclear neutrophil activity, mononuclear infiltration, and surface epithelial erosion in both pyloric and fundic mucosae compared with those of the control group. H. pylori inoculation significantly increased the heights of both pyloric and fundic mucosae (mainly due to the increased height of foveolar hyperplasia), but polaprezinc inhibited the increase of mucosal thickness in both pyloric and fundic mucasae. No intestinal metaplasia was detected in this study. Spectrophotometric examination revealed that polaprezinc scavenged monochloramine.
CONCLUSIONS: Polaprezinc inhibited the development of H. pylori-induced gastritis through its scavenging action against monochloramine.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12485126     DOI: 10.1046/j.1523-5378.2002.00114.x

Source DB:  PubMed          Journal:  Helicobacter        ISSN: 1083-4389            Impact factor:   5.753


  6 in total

1.  Polaprezinc protects human colon cells from oxidative injury induced by hydrogen peroxide: relevant to cytoprotective heat shock proteins.

Authors:  Tatsuya Ohkawara; Jun Nishihira; Rika Nagashima; Hiroshi Takeda; Masahiro Asaka
Journal:  World J Gastroenterol       Date:  2006-10-14       Impact factor: 5.742

2.  Polaprezinc combined with clarithromycin-based triple therapy for Helicobacter pylori-associated gastritis: A prospective, multicenter, randomized clinical trial.

Authors:  Bei Tan; Han-Qing Luo; Hong Xu; Nong-Hua Lv; Rui-Hua Shi; He-Sheng Luo; Jian-Sheng Li; Jian-Lin Ren; Yi-You Zou; Yan-Qing Li; Feng Ji; Jing-Yuan Fang; Jia-Ming Qian
Journal:  PLoS One       Date:  2017-04-13       Impact factor: 3.240

3.  Zinc carnosine-based modified bismuth quadruple therapy vs standard triple therapy for Helicobacter pylori eradication: A randomized controlled study.

Authors:  Nour Ibrahim; Hassan El Said; Ali Choukair
Journal:  World J Clin Cases       Date:  2022-01-07       Impact factor: 1.337

4.  Association between dietary antioxidant index and risk of Helicobacter pylori infection among adults: a case-control study.

Authors:  Zohreh Ebrahimi; Mohsen Masoodi; Zahra Aslani; Sina Naghshi; Masoumeh Khalighi Sikaroudi; Farzad Shidfar
Journal:  BMC Gastroenterol       Date:  2022-09-06       Impact factor: 2.847

Review 5.  Efficacy and Safety of Polaprezinc-Based Therapy versus the Standard Triple Therapy for Helicobacter pylori Eradication: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Abdelrahman Mahmoud; Mohamed Abuelazm; Ali Ashraf Salah Ahmed; Hassan Abdalshafy; Basel Abdelazeem; James Robert Brašić
Journal:  Nutrients       Date:  2022-10-04       Impact factor: 6.706

Review 6.  Histidine in Health and Disease: Metabolism, Physiological Importance, and Use as a Supplement.

Authors:  Milan Holeček
Journal:  Nutrients       Date:  2020-03-22       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.